The TGF-β/ miR-196a-3p/ NRP2 axis could provide further insight into the pathogenesis of breast cancer, and miR-196a-3p might be a potential diagnostic and therapeutic target for the metastasis of breast cancer. This evidence concerns the gene TGFB1 and breast carcinoma.